Aim. To evaluate standard 12-lead electrocardiogram (ECG) indices for the differential diagnosis of left bundle branch block (LBBB) tachycardias.Material and Methods. The study analyses 244 ECG indices in 63 retrospective patients (85 males and 39 females aged 50±12 years) with LBBB type tachycardias. The electrophysiological study identified ventricular tachycardias (VT) (VT group, n=20), supraventricular tachycardias (SVT) with LBBB (SVT+LBBB group, n=23) or antidromic SVTs (WPW group, n=20). Unifactorial, multifactorial, and ROC analyses were performed to develop diagnostic ECG algorithms. The prognostic accuracy of the algorithms was subsequently evaluated in a prospective group of patients with LBBB tachycardias (n=57).Results. ECG signs of LBBB VTs were as follows: 1) the presence of the initial R wave in the lead aVL; 2) the absence of a split (M-shaped) R wave in the lead I; and 3) the S wave duration in the lead V1≤100 ms. For antidromic LBBB tachycardias, the ECG signs were as follows: 1) the duration of the R waves in the lead V2≥45 ms; 2) the absence of a split R waves (M-shaped) in the lead I; and 3) the duration of the R wave in the lead aVL>30 ms. The accuracy of the algorithm for diagnosis of VT with LBBB was 95% (sensitivity of 97%, specificity of 92%). The accuracy of the algorithm for diagnosis of antidromic tachycardias was 84% (sensitivity rate of 65%, specificity rate of 100%).Conclusion. Our data showed new very powerful criteria for differential diagnosis between various LBBB tachycardias even in comparison with well-known ECG algorithms of Wellens, Brugada, Griffith, Scheinman, Vereckei, Sasaki, et al.
This work aimed to study the efficacy and safety of the class III antiarrhythmic agent cavutilide (Niferidil, Refralon) for pharmacological cardioversion in patients with paroxysmal and persistent atrial fibrillation (AF) and heart failure (HF). Methods and Results: In this retrospective cohort study, 58 patients with stable HF (aged 69 [61;73] years, 30 males, 78% with persistent AF) and 274 patients without HF (aged 63 [57;70] years, 196 males, 56% with persistent AF) were included. The median AF duration in the group with HF was 35.5 [10.6;124] days, and that in the group without HF was 14.5 [3.6;90] days. All patients received 5–30 µg/kg cavutilide intravenously in one to four (if needed) boluses of 5–5–10–10 µg/kg at 15 min intervals. Subsequent boluses were not administered if the patient’s sinus rhythm (SR) was restored or if bradycardia, QT prolongation > 500 ms or evidence of proarrhythmia was observed. Holter electrocardiogram monitoring was started before infusion and was continued for 24 h. The main criterion for an antiarrhythmic effect was sinus rhythm restoration within 24 h of the initial bolus. Results: Cavutilide converted AF to SR in 37.9% of patients with HF after bolus 1 (5 µg/kg), in 58.6% after bolus 2 (cumulative dose = 10 µg/kg), in 74% of cases after bolus 3 (cumulative dose = 20 µg/kg) and in 92.8% of cases after bolus 4 (cumulative dose = 30 µg/kg). Cavutilide was effective in 89% of cases with persistent AF with a median duration of 70.5 [30;159] days and in 92% of cases with paroxysmal AF with a median duration of 36 [24;102] h. In the group of patients without HF, the effectiveness of bolus 1 was 36.9%, that of the bolus 2 was 58%, that of the bolus 3 was 77% and that of the bolus 4 was 90.1%. Cavutilide restored SR in 90% of patients with persistent AF with a median duration of 82.5 [28;180] days and in 90% of cases with paroxysmal AF with a median duration of 50 [24;120] h. No statistically significant difference in the probability of SR restoration or the effectiveness of each bolus of cavutilide was found between patients with and without HF. The median time to restoration of SR in patients with HF was 23 [11;55] min, and that in patients without HF was 22 [10;45] min (p = 0.424). No cases of symptomatic/severe bradycardia were observed in either group. QT prolongation over 500 ms after cavutilide injection was registered in 19% of patients without HF and in 15.5% of those with HF (p = 0.58). Short runs of Torsade de pointes tachycardia occurred in one patient (0.4%) without HF after 10 µg cavutilide administration and were successfully treated with MgSO4. Conclusions: Cavutilide demonstrated a high likelihood of AF conversion to SR in paroxysmal (92%) and persistent (89%) arrhythmia and HF. Concomitant HF and its severity do not affect the efficacy and safety of cavutilide.
Цель. Сравнительное изучение параметров внутрисердечного электрофизиологического исследования (ЭФИ) у больных с типичным трепетанием предсердий (ТТП) и фибрилляцией предсердий (ФП), протекающих в формах изолированных аритмий, а также при их сочетании. Материал и методы. Включено 82 больных (59 (72%) мужчин, средний возраст 55 ± 10 лет), направленных для проведения катетерной аблации по поводу ТТП и ФП. Исходя из анамнеза аритмии, больные разделены на 4 группы: №1 – изолированное ТТП (n=26, 32%), №2 – сочетание ФП и «спонтанного» ТТП (n=27, 33%), №3 – ФП и ТТП, где последнее регистрировалось исключительно в условиях применения антиаритмических препаратов IC и III класса (n=14, 17%), №4 – изолированная ФП (n=15, 18%). Всем пациентам выполнено ЭФИ на фоне синусового ритма в условиях отмены антиаритмической терапии. В ходе ЭФИ определены следующие показатели: длительность Р - волны, время межпредсердного и внутрипредсердного проведения, эффективные рефрактерные периоды (ЭРП) в различных областях предсердий. По результатам ЭФИ проведен сравнительный статистический анализ вышеперечисленных признаков между изучаемыми группами. Результаты. Больные с ТТП (группы № 1, 2 и 3) в отличие от пациентов с изолированной ФП (группа №4) характеризовались достоверно большей длительностью Р – волны и удлинением времени межпредсердного проведения. Анализ определения ЭРП показал сходную гетерогенность показателей в различных областях предсердий во всех изучаемых группах: наименьшая величина ЭРП выявлена в латеральной области правого предсердия, наибольшая - в дистальном отделе коронарного синуса. Межгрупповые различия по этим параметрам были статистически не значимы. Заключение. Для пациентов с ТТП, протекающим как изолированной форме, так и при сочетании с ФП, характерным является существенное замедление времени межпредсердного проведения импульса, что может объяснять у них склонность к развитию тахиаритмий по механизму макро-reentry.
23 April 2019 in Siberian Journal of Clinical and Experimental Medicine
Aim. To evaluate standard 12-lead electrocardiogram (ECG) indices for the differential diagnosis of left bundle branch block (LBBB) tachycardias.Material and Methods. The study analyses 244 ECG indices in 63 retrospective patients (85 males and 39 females aged 50±12 years) with LBBB type tachycardias. The electrophysiological study identified ventricular tachycardias (VT) (VT group, n=20), supraventricular tachycardias (SVT) with LBBB (SVT+LBBB group, n=23) or antidromic SVTs (WPW group, n=20). Unifactorial, multifactorial, and ROC analyses were performed to develop diagnostic ECG algorithms. The prognostic accuracy of the algorithms was subsequently evaluated in a prospective group of patients with LBBB tachycardias (n=57).Results. ECG signs of LBBB VTs were as follows: 1) the presence of the initial R wave in the lead aVL; 2) the absence of a split (M-shaped) R wave in the lead I; and 3) the S wave duration in the lead V1≤100 ms. For antidromic LBBB tachycardias, the ECG signs were as follows: 1) the duration of the R waves in the lead V2≥45 ms; 2) the absence of a split R waves (M-shaped) in the lead I; and 3) the duration of the R wave in the lead aVL>30 ms. The accuracy of the algorithm for diagnosis of VT with LBBB was 95% (sensitivity of 97%, specificity of 92%). The accuracy of the algorithm for diagnosis of antidromic tachycardias was 84% (sensitivity rate of 65%, specificity rate of 100%).Conclusion. Our data showed new very powerful criteria for differential diagnosis between various LBBB tachycardias even in comparison with well-known ECG algorithms of Wellens, Brugada, Griffith, Scheinman, Vereckei, Sasaki, et al.